본문 바로가기
KERD
논문KCI 등재

A Newly Synthesized Flavone from Luteolin Escapes from COMT-Catalyzed Methylation and Inhibits Lipopolysaccharide-Induced Inflammation in RAW264.7 Macrophages via JNK, p38 and NF-κB Signaling Pathways

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Luteolin is a common dietary flavone possessing potent anti-inflammatory activities. However, when administrated in vivo, luteolin becomes methylated by catechol-O-methyltransferases (COMT) owing to the catechol ring in the chemical structure, which largely diminishes its anti-inflammatory effect. In this study, we made a modification on luteolin, named LUA, which was generated by the chemical reaction between luteolin and 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH). Without a catechol ring in the chemical structure, this new flavone could escape from the COMTcatalyzed methylation, thus affording the potential to exert its functions in the original form when administrated in the organism. Moreover, an LPS-stimulated RAW cell model was applied to detect the anti-inflammatory properties. LUA showed much more superior inhibitory effect on LPS-induced production of NO than diosmetin (a major methylated form of luteolin) and significantly suppressed upregulation of iNOS and COX-2 in macrophages. LUA treatment dramatically reduced LPSstimulated reactive oxygen species (ROS) and mRNA levels of pro-inflammatory mediators such as IL-1β, IL-6, IL-8 and IFN-β. Furthermore, LUA significantly reduced the phosphorylation of JNK and p38 without affecting that of ERK. LUA also inhibited the activation of NF-κB through suppression of p65 phosphorylation and nuclear translocation.

Abstract

Luteolin is a common dietary flavone possessing potent anti-inflammatory activities. However, when administrated in vivo, luteolin becomes methylated by catechol-O-methyltransferases (COMT) owing to the catechol ring in the chemical structure, which largely diminishes its anti-inflammatory effect. In this study, we made a modification on luteolin, named LUA, which was generated by the chemical reaction between luteolin and 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH). Without a catechol ring in the chemical structure, this new flavone could escape from the COMTcatalyzed methylation, thus affording the potential to exert its functions in the original form when administrated in the organism. Moreover, an LPS-stimulated RAW cell model was applied to detect the anti-inflammatory properties. LUA showed much more superior inhibitory effect on LPS-induced production of NO than diosmetin (a major methylated form of luteolin) and significantly suppressed upregulation of iNOS and COX-2 in macrophages. LUA treatment dramatically reduced LPSstimulated reactive oxygen species (ROS) and mRNA levels of pro-inflammatory mediators such as IL-1β, IL-6, IL-8 and IFN-β. Furthermore, LUA significantly reduced the phosphorylation of JNK and p38 without affecting that of ERK. LUA also inhibited the activation of NF-κB through suppression of p65 phosphorylation and nuclear translocation.

참고문헌 (78)

  1. Mijung Yeom, "Xanthii fructus inhibits inflammatory responses in LPS-stimulated RAW 264.7 macrophages through suppressing NF-κB and JNK", p38 MAPK, 2015, pp.176, 394~401[DOI]
  2. Erwig LP, "Macrophage activation and programming and its role for macrophage function in glomerular inflammation", Kidney Blood Press. Res, 22, pp.21~25 (1999)
  3. Hoffmann JA, "Phylogenetic perspectives in innate immunity", Science, 284, pp.1313~1318 (1999)
  4. King GL, "The role of inflammatory cytokines in diabetes and its complications", J. Periodontol, 79, pp.1527~1534 (2008)
  5. Kundu JK, "Inflammation : gearing the journey to cancer", Mutat. Res, 659, pp.15~30 (2008)
  6. Manzi S, "Inflammation-mediated rheumatic diseases and atherosclerosis", Ann. Rheum. Dis, 59, pp.321~325 (2000)
  7. Balkwill F, "Inflammation and cancer : Back to Virchow?", Lancet, 357, pp.539~545 (2001)
  8. Manach C, "Polyphenols : food sources and bioavailability", Am. J. Clin. Nutr, 79, pp.727~747 (2004)
  9. Feng X, "Chrysin attenuates inflammation by regulating M1", M2 status via activating PPARgamma, 2014, pp.89, 503~514
  10. Ruiz PA, "Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells", J. Nutr, 136, pp.664~671 (2006)
  11. Qian LB, "Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress", Pharmacol. Res, 61, pp.281~287 (2010)
  12. Jennings A, "Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women", J. Nutr, 144, pp.202~208 (2014)
  13. Lin Y, "Luteolin, a flavonoid with potential for cancer prevention and therapy", Curr. Cancer Drug Targets, 8, pp.634~646 (2008)
  14. Cheng-Wei Liu, "Luteolin inhibits viral-induced inflammatory response in RAW264.7 cells via suppression of STAT1", 3 dependent NF-κB and activation of HO-1, 2016, pp.95, 180~189[DOI]
  15. Wolfle U, "UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo", Free Radic. Biol. Med, 50, pp.1081~1093 (2011)
  16. Pratheeshkumar P, "Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways", Toxicol. Appl. Pharmacol, 281, pp.230~241 (2014)
  17. Kwon EY, "Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity", Diabetes, 64, pp.1658~1669 (2015)
  18. Seelinger G, "Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin", Planta Med, 74, pp.1667~1677 (2008)
  19. Cheng-Wei Liu, "Luteolin inhibits viral-induced inflammatory response in RAW264.7 cells via suppression of STAT1", 3 dependent NF-κB and activation of HO-1, 2016, pp.95, 180~189[DOI]
  20. Wu W, "Luteolin inhibits inflammatory responses via p38", MK2, Molecules, pp.2013, 18[DOI]
  21. Fei J, "Luteolin inhibits IL-1beta-induced in flammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model", Biomed. Pharmacother, 109, pp.1586~1592 (2019)
  22. Chen Z, "The exposure of luteolin is much lower than that of apigenin in oral administration of Flos Chrysanthemi extract to rats", Drug Metab. Pharmacokinet, 27, pp.162~168 (2012)
  23. Guldberg HC, "Catechol-O-methyl transferase : pharmacological aspects and physiological role", Pharmacol. Rev, 27, pp.135~206 (1975)
  24. Nissinen E, "Catechol-O-methyltransferase activity in human and rat small intestine", Life Sci, 42, pp.2609~2614 (1988)
  25. Schultz E, "Catechol-O-methyltransferase and aromatic L-amino acid decarboxylase activities in human gastrointestinal tissues", Life Sci, 49, pp.721~725 (1991)
  26. Mannisto PT, "Catechol-O-methyltransferase(COMT) : biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors", Pharmacol. Rev, 51, pp.593~628 (1999)
  27. Meloto CB, "COMT gene locus : new functional variants", Pain, 156, pp.2072~2083 (2015)
  28. Chen ZJ, "Luteolin is a rare substrate of human catechol-O-methyltransferase favoring a para-methylation", Mol. Nutr. Food Res, 57, pp.877~885 (2013)
  29. Chen Z, "Role of catechol-O-methyltransferase in the disposition of luteolin in rats", Drug Metab. Dispos, 39, pp.667~674 (2011)
  30. Wang L, "Metabolic Disposition of Luteolin is mediated by the interplay of UDPGlucuronosyltransferases and Catechol-O-Methyltransferases in rats", Drug Metab. Dispos, 45, pp.306~315 (2017)
  31. Ha SK, "Effects of Catechol O-Methyl Transferase inhibition on anti-inflammatory activity of luteolin metabolites", J. Food Sci, 82, pp.545~552 (2017)
  32. Parashos SA, "Frequency, reasons, and risk factors of entacapone discontinuation in Parkinson disease", Clin. Neuropharmacol, 27, pp.119~123 (2004)
  33. Assal F, "Tolcapone and fulminant hepatitis", Lancet, 352, pp.958~ (1998)
  34. Olanow CW, "Tolcapone and hepatotoxic effects", Tasmar advisory panel. Arch. Neurol, 57, pp.263~267 (2000)
  35. DeLeo FR, "Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly", J. Clin. Invest, 101, pp.455~463 (1998)
  36. Keller JN, "Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines", Brain Res, 830, pp.10~15 (1999)
  37. Kaminska B, "MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits", Biochim. Biophys. Acta, 1754, pp.253~262 (2005)
  38. Young-Sang Kim, "Anti-inflammatory action of high molecular weight Mytilus edulis hydrolysates fraction in LPS-induced RAW264.7 macrophage via NF-κB and MAPK pathways", Food Chemistry, 202, pp.9~14 (2016), Elsevier BV[DOI]
  39. Fuyan Liu, "Immunomodulatory effects of xanthan gum in LPS-stimulated RAW 264.7 macrophages", Carbohydrate Polymers, 169, pp.65~74 (2017), Elsevier BV[DOI]
  40. Jianhua Shan, "Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-κB and JNK", AP-1 activation, 2009, pp.9(9), 1042~1048[DOI]
  41. Samuel J. Ajizian, "Specific Inhibitors of p38 and Extracellular Signal‐Regulated Kinase Mitogen‐Activated Protein Kinase Pathways Block Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Accumulation in Murine Macrophages Stimulated with Lipopolysaccharide and Interferon‐γ", The Journal of Infectious Diseases, 179(4), pp.939~944 (1999), Oxford University Press (OUP)[DOI]
  42. Nur Aziz, "Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies", Journal of Ethnopharmacology, 225, pp.342~358 (2018), Elsevier BV[DOI]
  43. Yang Cao, "Computational studies of the regioselectivities of COMT-catalyzed meta-", para-O methylations of luteolin and quercetin, 2014, pp.118(2), 470~481[DOI]
  44. Eisenhofer G, "Catecholamine metabolism : a contemporary view with implications for physiology and medicine", Pharmacol. Rev, 56, pp.331~349 (2004)
  45. Kopin IJ, "Catecholamine metabolism : basic aspects and clinical significance", Pharmacol. Rev, 37, pp.333~364 (1985)
  46. Dooley MM, "Effects of 2, 2'-azobis(2-amidinopropane)hydrochloride in vivo and protection by vitamin E", Free Radic. Biol. Med, 9, pp.199~204 (1990)
  47. Muraoka S, "Protection by estrogens of biological damage by 2, 2'-azobis(2-amidinopropane)dihydrochloride", J. Steroid Biochem. Mol. Biol, 82, pp.343~348 (2002)
  48. Kanazawa K, "Bioavailable flavonoids to suppress the formation of 8-OHdG in HepG2cells", Arch. Biochem. Biophys, 455, pp.197~203 (2006)
  49. Edenharder R, "Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102", Mutat. Res, 540, pp.1~18 (2003)
  50. Huang D, "High-throughput assay of oxygen radical absorbance capacity(ORAC)using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format", J. Agric. Food Chem, 50, pp.4437~4444 (2002)
  51. Zuvela P, "Non-Linear quantitative structure(-)activity relationships modelling, mechanistic study and in-silico design of flavonoids as potent antioxidants", Int. J. Mol. Sci, 20, pp.2328~ (2019)
  52. Kumar KJ, "Lucidone protects human skin keratinocytes against free radical-induced oxidative damage and inflammation through the up-regulation of HO-1", Nrf2 antioxidant genes and downregulation of NF-kappaB signaling pathway, 2013, pp.59, 55~66
  53. Zeinali M, "An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances", Biomed. Pharmacother, 92, pp.998~1009 (2017)
  54. Manthey JA, "Biological properties of citrus flavonoids pertaining to cancer and inflammation", Curr. Med. Chem, 8, pp.135~153 (2001)
  55. Lee JO, "ATP-binding pocket-targeted suppression of Src and Syk by luteolin contributes to its antiinflammatory action", Mediators Inflamm, 2015, pp.967053~ (2015)
  56. Chung Mu Park, "Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3K-Akt pathway and impairment of NF-κB translocation in LPS stimulated RAW 264.7 cells", European Journal of Pharmacology, 660(2-3), pp.454~459 (2011), Elsevier BV[DOI]
  57. 박충무, "Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-κB", AP-1, Nutrition Research and Practice, pp.2013, 7(6)[DOI]
  58. Chung Mu Park, "Taraxacum officinale Weber extracts inhibit LPS-induced oxidative stress and nitric oxide production via the NF-κB modulation in RAW 264.7 cells", Journal of Ethnopharmacology, 133(2), pp.834~842 (2011), Elsevier BV[DOI]
  59. Biswas SK, "Does the Interdependence between oxidative stress and inflammation explain the antioxidant paradox?", Oxid. Med. Cell. Longev, 2016, pp.5698931~ (2016)
  60. Gao B, "Inflammation in alcoholic and nonalcoholic fatty liver disease : friend or foe?", Gastroenterology, 150, pp.1704~1709 (2016)
  61. Lam P, "Hepatoprotective effects of chinese medicinal herbs : a focus on antiinflammatory and anti-oxidative activities", Int. J. Mol. Sci, 17, pp.465~ (2016)
  62. Ambade A, "Oxidative stress and inflammation : essential partners in alcoholic liver disease", Int. J. Hepatol, pp.853175~ (2012)
  63. Robak J, "Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation", Pol. J. Pharmacol. Pharm, 40, pp.451~458 (1988)
  64. Brown JE, "Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro", Free Rradic. Res, 29, pp.247~255 (1998)
  65. Zhang T, "Anti-oxidant and anti-apoptotic effects of luteolin on mice peritoneal macrophages stimulated by angiotensin II", Int. Immunopharmacol, 20, pp.346~351 (2014)
  66. Qingsong Xu, "The inhibition of LPS-induced inflammation in RAW264.7 macrophages via the PI3K", Akt pathway by highly N-acetylated chitooligosaccharide, 2017, pp.174, 1138~1143[DOI]
  67. 이지애, "Differential regulation of inducible nitric oxide synthase and cyclooxygenase-2 expression by superoxide dismutase in lipopolysaccharide stimulated RAW 264.7 cells", Experimental and Molecular Medicine, 41(9), pp.629~637 (2009), 생화학분자생물학회
  68. Bhat NR, "Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures", J. Neurosci, 18, pp.1633~1641 (1998)
  69. Hambleton J, "Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharidestimulated macrophages", Proc. Nat. Acad. Sci. USA, 93, pp.2774~2778 (1996)
  70. Hommes DW, "Mitogen activated protein(MAP)kinase signal transduction pathways and novel anti-inflammatory targets", Gut, 52, pp.144~151 (2003)
  71. Chen D, "Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages", Biochem. Biophys. Res. Commun, 443, pp.326~332 (2014)
  72. Milanovic M, "The cytokine-induced conformational switch of nuclear factor kappaB p65 is mediated by p65 phosphorylation", Biochem. J, 457, pp.401~413 (2014)
  73. Qian Z, "Mulberry fruit prevents LPS-induced NF-kappaB", pERK, Sci. Rep, pp.2015, 5[DOI]
  74. Perkins ND, "Integrating cell-signalling pathways with NF-kappaB and IKK function", Nature reviews. Mol. Cell Biol, 8, pp.49~62 (2007)
  75. B activity, "Ann. Rev. Immunol", 2000, 621~663
  76. Gloire G, "NF-kappaB activation by reactive oxygen species : fifteen years later", Biochem. Pharmacol, 72, pp.1493~1505 (2006)
  77. 성지혜, "Anti-Inflammatory Activity of Butein and Luteolin Through Suppression of NFjB Activation and Induction of Heme Oxygenase-1", Journal of Medicinal Food, 18(5), pp.557~564 (2015), 한국식품영양과학회[DOI]
  78. Mi-Zhen Xia, "Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells", Journal of Pineal Research, 53(4), pp.325~334 (2012), Wiley[DOI]

관련 논문AI추천

Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-κB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells박충무, 송영선한국영양학회 · Nutrition Research and Practice2013 · 제7권 제6호COX-2 inhibitory effect of luteolin through the regulation of NF-κB and ERK in phorbol ester activated human lung epithelial cells박충무사단법인 인문사회과학기술융합학회 · 예술인문사회 융합 멀티미디어 논문지2017 · 제7권 제5호Chloroform Extract from Fermented Viola mandshurica Regulates LPS-Induced Inflammation Response in RAW 264.7 Cells by Inhibiting iNOS and COX-2Cho Jong Hyun, Kim Hyunju, Kim Kyoung-Sook, Lee Young-Choon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 Luteolin and luteolin-7-O-glucoside protect against acute liver injury through regulation of inflammatory mediators and antioxidative enzymes in GalN/LPS-induced hepatitic ICR miceChung-Mu Park, Young-Sun Song한국영양학회 · Nutrition Research and Practice2019 · 제13권 제6호Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages김낙성, 김현수, 유종선, 이완식, 조성범, 주영은, Cho-Yun Chung, Eun Myung, Kang-Jin Park, So-Young Joo, Young-A Song, Young-Lan Park거트앤리버 소화기연관학회협의회 · Gut and Liver2012 · 제6권 제2호Salicortin suppresses lipopolysaccharide-stimulated inflammatory responses via blockade of NF-κB and JNK activation in RAW 264.7 macrophages권동주, 박진서, 배영수, 윤기수, 주성미, 최수영생화학분자생물학회 · BMB Reports2014 · 제47권 제6호

이 간행물의 다른 논문 (14건)